R Squared’s Amgen AMGN Stock Holding History

R Squared’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-833	Closed	-$293K	–	521
2026 Q1	$293K	Buy	+833	New	+$297K	0.16%	208
2025 Q1	–	Sell	-50	Closed	-$13K	–	346
2024 Q4	$13K	Buy	+50	New	+$14.8K	0.01%	1065

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

R Squared's AMGN Position: Q2 2026 in Review

R Squared sold out of Amgen (AMGN) in Q2 2026, closing a stake of 833 shares — an estimated $293K sold.

R Squared first reported a position in AMGN in Q4 2024 and held it in 2 quarters. The position peaked at $293K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

R Squared reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
R Squared sold 833 Amgen shares in Q2 2026, an estimated $293K.
R Squared first reported a position in Amgen in Q4 2024 and held it in 2 quarters.
R Squared's Amgen position peaked at $293K in Q1 2026.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.